The results demonstrated that CMC2.24 significantly reduced TLR-2 and p38 MAPK expressions involved in the inflammatory signaling cascade in a dog model of natural periodontitis; and inhibited NF-κB activation and inflammatory bone loss in murine models of LPS-induced experimental periodontitis and diabetes-associated natural periodontitis. This evidence concerns the gene TLR2 and diabetes mellitus.